Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
This report aims to provide a comprehensive presentation of the global market for Oncology Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Medication. This report contains market size and forecasts of Oncology Medication in global, including the following market information:
Global Oncology Medication Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Oncology Medication market was valued at US$ 203160 million in 2022 and is projected to reach US$ 340480 million by 2029, at a CAGR of 7.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
We surveyed the Oncology Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Medication Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Oncology Medication Market Segment Percentages, by Type, 2022 (%)
Chemotherapy Medication
Targeted Therapy Medication
Immunotherapy Medication
Hormonal Therapy Medication
Others
Global Oncology Medication Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Oncology Medication Market Segment Percentages, by Application, 2022 (%)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Global Oncology Medication Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Oncology Medication Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Medication revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oncology Medication revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology Medication, market overview.
Chapter 2: Global Oncology Medication market size in revenue.
Chapter 3: Detailed analysis of Oncology Medication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oncology Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Medication Overall Market Size
2.1 Global Oncology Medication Market Size: 2022 VS 2030
2.2 Global Oncology Medication Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Medication Players in Global Market
3.2 Top Global Oncology Medication Companies Ranked by Revenue
3.3 Global Oncology Medication Revenue by Companies
3.4 Top 3 and Top 5 Oncology Medication Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Medication Players in Global Market
3.6.1 List of Global Tier 1 Oncology Medication Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Medication Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Medication Market Size Markets, 2022 & 2030
4.1.2 Chemotherapy Medication
4.1.3 Targeted Therapy Medication
4.1.4 Immunotherapy Medication
4.1.5 Hormonal Therapy Medication
4.1.6 Others
4.2 By Type - Global Oncology Medication Revenue & Forecasts
4.2.1 By Type - Global Oncology Medication Revenue, 2018-2023
4.2.2 By Type - Global Oncology Medication Revenue, 2024-2030
4.2.3 By Type - Global Oncology Medication Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Medication Market Size, 2022 & 2030
5.1.2 Blood Cancer
5.1.3 Breast Cancer
5.1.4 Gastrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Respiratory or Lung Cancer
5.1.7 Others
5.2 By Application - Global Oncology Medication Revenue & Forecasts
5.2.1 By Application - Global Oncology Medication Revenue, 2018-2023
5.2.2 By Application - Global Oncology Medication Revenue, 2024-2030
5.2.3 By Application - Global Oncology Medication Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Oncology Medication Market Size, 2022 & 2030
6.2 By Region - Global Oncology Medication Revenue & Forecasts
6.2.1 By Region - Global Oncology Medication Revenue, 2018-2023
6.2.2 By Region - Global Oncology Medication Revenue, 2024-2030
6.2.3 By Region - Global Oncology Medication Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Oncology Medication Revenue, 2018-2030
6.3.2 US Oncology Medication Market Size, 2018-2030
6.3.3 Canada Oncology Medication Market Size, 2018-2030
6.3.4 Mexico Oncology Medication Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Oncology Medication Revenue, 2018-2030
6.4.2 Germany Oncology Medication Market Size, 2018-2030
6.4.3 France Oncology Medication Market Size, 2018-2030
6.4.4 U.K. Oncology Medication Market Size, 2018-2030
6.4.5 Italy Oncology Medication Market Size, 2018-2030
6.4.6 Russia Oncology Medication Market Size, 2018-2030
6.4.7 Nordic Countries Oncology Medication Market Size, 2018-2030
6.4.8 Benelux Oncology Medication Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Oncology Medication Revenue, 2018-2030
6.5.2 China Oncology Medication Market Size, 2018-2030
6.5.3 Japan Oncology Medication Market Size, 2018-2030
6.5.4 South Korea Oncology Medication Market Size, 2018-2030
6.5.5 Southeast Asia Oncology Medication Market Size, 2018-2030
6.5.6 India Oncology Medication Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Oncology Medication Revenue, 2018-2030
6.6.2 Brazil Oncology Medication Market Size, 2018-2030
6.6.3 Argentina Oncology Medication Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Medication Revenue, 2018-2030
6.7.2 Turkey Oncology Medication Market Size, 2018-2030
6.7.3 Israel Oncology Medication Market Size, 2018-2030
6.7.4 Saudi Arabia Oncology Medication Market Size, 2018-2030
6.7.5 UAE Oncology Medication Market Size, 2018-2030
7 Oncology Medication Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Oncology Medication Major Product Offerings
7.1.4 Roche Oncology Medication Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Celgene
7.2.1 Celgene Company Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene Oncology Medication Major Product Offerings
7.2.4 Celgene Oncology Medication Revenue in Global Market (2018-2023)
7.2.5 Celgene Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Oncology Medication Major Product Offerings
7.3.4 Novartis Oncology Medication Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Oncology Medication Major Product Offerings
7.4.4 Bristol-Myers Squibb Oncology Medication Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Oncology Medication Major Product Offerings
7.5.4 Johnson & Johnson Oncology Medication Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Merck & Co.
7.6.1 Merck & Co. Company Summary
7.6.2 Merck & Co. Business Overview
7.6.3 Merck & Co. Oncology Medication Major Product Offerings
7.6.4 Merck & Co. Oncology Medication Revenue in Global Market (2018-2023)
7.6.5 Merck & Co. Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Oncology Medication Major Product Offerings
7.7.4 AstraZeneca Oncology Medication Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Oncology Medication Major Product Offerings
7.8.4 Pfizer Oncology Medication Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Oncology Medication Major Product Offerings
7.9.4 Amgen Oncology Medication Revenue in Global Market (2018-2023)
7.9.5 Amgen Key News & Latest Developments
7.10 Takeda
7.10.1 Takeda Company Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Oncology Medication Major Product Offerings
7.10.4 Takeda Oncology Medication Revenue in Global Market (2018-2023)
7.10.5 Takeda Key News & Latest Developments
7.11 Astellas
7.11.1 Astellas Company Summary
7.11.2 Astellas Business Overview
7.11.3 Astellas Oncology Medication Major Product Offerings
7.11.4 Astellas Oncology Medication Revenue in Global Market (2018-2023)
7.11.5 Astellas Key News & Latest Developments
7.12 Ipsen
7.12.1 Ipsen Company Summary
7.12.2 Ipsen Business Overview
7.12.3 Ipsen Oncology Medication Major Product Offerings
7.12.4 Ipsen Oncology Medication Revenue in Global Market (2018-2023)
7.12.5 Ipsen Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Business Overview
7.13.3 Sanofi Oncology Medication Major Product Offerings
7.13.4 Sanofi Oncology Medication Revenue in Global Market (2018-2023)
7.13.5 Sanofi Key News & Latest Developments
7.14 Bayer
7.14.1 Bayer Company Summary
7.14.2 Bayer Business Overview
7.14.3 Bayer Oncology Medication Major Product Offerings
7.14.4 Bayer Oncology Medication Revenue in Global Market (2018-2023)
7.14.5 Bayer Key News & Latest Developments
7.15 Biogen Idec
7.15.1 Biogen Idec Company Summary
7.15.2 Biogen Idec Business Overview
7.15.3 Biogen Idec Oncology Medication Major Product Offerings
7.15.4 Biogen Idec Oncology Medication Revenue in Global Market (2018-2023)
7.15.5 Biogen Idec Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oncology Medication Market Opportunities & Trends in Global Market
Table 2. Oncology Medication Market Drivers in Global Market
Table 3. Oncology Medication Market Restraints in Global Market
Table 4. Key Players of Oncology Medication in Global Market
Table 5. Top Oncology Medication Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oncology Medication Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oncology Medication Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oncology Medication Product Type
Table 9. List of Global Tier 1 Oncology Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oncology Medication Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Oncology Medication Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oncology Medication Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Oncology Medication Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Oncology Medication Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oncology Medication Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Oncology Medication Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Oncology Medication Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oncology Medication Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Oncology Medication Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oncology Medication Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Oncology Medication Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oncology Medication Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Oncology Medication Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oncology Medication Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Oncology Medication Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oncology Medication Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Oncology Medication Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oncology Medication Revenue, (US$, Mn), 2024-2030
Table 30. Roche Company Summary
Table 31. Roche Oncology Medication Product Offerings
Table 32. Roche Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Celgene Company Summary
Table 35. Celgene Oncology Medication Product Offerings
Table 36. Celgene Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 37. Celgene Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Oncology Medication Product Offerings
Table 40. Novartis Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Oncology Medication Product Offerings
Table 44. Bristol-Myers Squibb Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Oncology Medication Product Offerings
Table 48. Johnson & Johnson Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Merck & Co. Company Summary
Table 51. Merck & Co. Oncology Medication Product Offerings
Table 52. Merck & Co. Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 53. Merck & Co. Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Oncology Medication Product Offerings
Table 56. AstraZeneca Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Oncology Medication Product Offerings
Table 60. Pfizer Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Amgen Company Summary
Table 63. Amgen Oncology Medication Product Offerings
Table 64. Amgen Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 65. Amgen Key News & Latest Developments
Table 66. Takeda Company Summary
Table 67. Takeda Oncology Medication Product Offerings
Table 68. Takeda Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 69. Takeda Key News & Latest Developments
Table 70. Astellas Company Summary
Table 71. Astellas Oncology Medication Product Offerings
Table 72. Astellas Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 73. Astellas Key News & Latest Developments
Table 74. Ipsen Company Summary
Table 75. Ipsen Oncology Medication Product Offerings
Table 76. Ipsen Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 77. Ipsen Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Oncology Medication Product Offerings
Table 80. Sanofi Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 81. Sanofi Key News & Latest Developments
Table 82. Bayer Company Summary
Table 83. Bayer Oncology Medication Product Offerings
Table 84. Bayer Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 85. Bayer Key News & Latest Developments
Table 86. Biogen Idec Company Summary
Table 87. Biogen Idec Oncology Medication Product Offerings
Table 88. Biogen Idec Oncology Medication Revenue (US$, Mn) & (2018-2023)
Table 89. Biogen Idec Key News & Latest Developments
List of Figures
Figure 1. Oncology Medication Segment by Type in 2022
Figure 2. Oncology Medication Segment by Application in 2022
Figure 3. Global Oncology Medication Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncology Medication Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Oncology Medication Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Medication Revenue in 2022
Figure 8. By Type - Global Oncology Medication Revenue Market Share, 2018-2030
Figure 9. By Application - Global Oncology Medication Revenue Market Share, 2018-2030
Figure 10. By Type - Global Oncology Medication Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Oncology Medication Revenue Market Share, 2018-2030
Figure 12. By Application - Global Oncology Medication Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Oncology Medication Revenue Market Share, 2018-2030
Figure 14. By Region - Global Oncology Medication Revenue Market Share, 2018-2030
Figure 15. By Country - North America Oncology Medication Revenue Market Share, 2018-2030
Figure 16. US Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Oncology Medication Revenue Market Share, 2018-2030
Figure 20. Germany Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 21. France Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Oncology Medication Revenue Market Share, 2018-2030
Figure 28. China Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 32. India Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Oncology Medication Revenue Market Share, 2018-2030
Figure 34. Brazil Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Oncology Medication Revenue Market Share, 2018-2030
Figure 37. Turkey Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Oncology Medication Revenue, (US$, Mn), 2018-2030
Figure 41. Roche Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Celgene Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck & Co. Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Amgen Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takeda Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Astellas Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Ipsen Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sanofi Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Bayer Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Biogen Idec Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
